KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market 

KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market 

Strategic collaboration combines KYBORA’s global biopharma network with ACA Pharma’s 30–90 day Macau registration model to expedite access for rare disease and pediatric therapies in China.  KYBORA and ACA Pharma…
READ MORE
Anton Leshchenko- Kybora

KYBORA Welcomes Anton Leshchenko to the Team

KYBORA is pleased to announce that Anton Leshchenko has joined its team as Managing Director, responsible for expanding KYBORA’s operations…
READ MORE
Rainer Wulf- Kybora

KYBORA Welcomes Rainer Wulf to the Team

KYBORA is pleased to announce that Rainer Wulf has joined Kybora as a new member of the advisory board. Rainer…
READ MORE

KYBORA Successfully Helps STADA License Xlucane to Bausch Health

READ MORE

TYPE & ENTER: